Dow; Geoffrey S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dow; Geoffrey S..The latest application filed is for "methods for the treatment and prevention of lung infections caused by gram-positive bacteria, fungus, or virus by administration of tafenoquine".

Company Profile

5.5.7

Dow; Geoffrey S. - Washington DC
Dow; Geoffrey S. - DC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dosing regimens of celgosivir for the treatment of dengue Grant 11,219,616 - Dow , et al. January 11, 2	2022-01-11
Regimens of Tafenoquine for Prevention of Malaria in Malaria-Naive Subjects App 20210267962 - Dow; Geoffrey S. ; et al.	2021-09-02
Methods For The Treatment And Prevention Of Lung Infections Caused By Gram-positive Bacteria, Fungus, Or Virus By Administration Of Tafenoquine App 20210267963 - Dow; Geoffrey S.	2021-09-02
Dosing regimens of celgosivir for the prevention of dengue Grant 11,000,516 - Vasudevan , et al. May 11, 2	2021-05-11
Regimens of tafenoquine for prevention of malaria in malaria-naive subjects Grant 10,888,558 - Dow , et al. January 12, 2	2021-01-12
Novel Dosing Regimens of Celgosivir for the Treatment of Dengue App 20200338050 - Dow; Geoffrey S. ; et al.	2020-10-29
Dosing regiments of celgosivir for the treatment of dengue Grant 10,517,854 - Dow , et al. Dec	2019-12-31
Novel Regimens of Tafenoquine for Prevention of Malaria in Malaria-Naive Subjects App 20190328723 - Dow; Geoffrey S. ; et al.	2019-10-31
Novel Dosing Regimens of Celgosivir For The Prevention of Dengue App 20180360809 - Vasudevan; Subhash ; et al.	2018-12-20
Novel Dosing Regimens of Celgosivir for the Treatment of Dengue App 20180064693 - Dow; Geoffrey S. ; et al.	2018-03-08
Dosing regimens of celgosivir for the treatment of dengue Grant 9,763,921 - Dow , et al. September 19, 2	2017-09-19
Novel Dosing Regimens of Celgosivir for the Treatment of Dengue App 20160030403 - DOW; Geoffrey S. ; et al.	2016-02-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.